Immune Checkpoint Inhibitor Therapy Aggravates T Cell–Driven Plaque Inflammation in Atherosclerosis-Reference-Cited by-同舟云学术

Immune Checkpoint Inhibitor Therapy Aggravates T Cell–Driven Plaque Inflammation in Atherosclerosis

Published:2020-11 Issue:4 Volume:2 Page:599-610
ISSN:2666-0873
Container-title:JACC: CardioOncology
language:en
Short-container-title:JACC: CardioOncology

Author:

Poels Kikkie,van Leent Mandy M.T.,Boutros Celine,Tissot Hubert,Roy Séverine,Meerwaldt Anu E.,Toner Yohana C.A.,Reiche Myrthe E.,Kusters Pascal J.H.,Malinova Tsveta,Huveneers Stephan,Kaufman Audrey E.,Mani Venkatesh,Fayad Zahi A.,de Winther Menno P.J.,Marabelle Aurelien,Mulder Willem J.M.,Robert Caroline,Seijkens Tom T.P.,Lutgens Esther

Funder

European Research Council

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Oncology

Reference40 articles.

1. Pembrolizumab versus ipilimumab in advanced melanoma;Robert;N Engl J Med,2015

3. T cell costimulatory and coinhibitory pathways in vascular inflammatory diseases;Lichtman;Front Physiol,2012

4. Immune checkpoint inhibitors: recent progress and potential biomarkers;Darvin;Exp Mol Med,2018

5. Five-year survival with combined nivolumab and ipilimumab in advanced melanoma;Larkin;N Engl J Med,2019

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thrombotic events associated with immune checkpoint inhibitors and novel antithrombotic strategies to mitigate bleeding risk;Blood Reviews;2024-09

2. Arterial inflammation on [18F]FDG PET/CT in melanoma patients treated with and without immune checkpoint inhibitors: CHECK-FLAME I;Atherosclerosis;2024-09

3. Cardiovascular toxicities of immune therapies for cancer – a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio‐Oncology;European Journal of Heart Failure;2024-08

4. Preclinical models of cardiotoxicity from immune checkpoint inhibitor therapy;Basic Research in Cardiology;2024-07-22

5. Molecular fingerprints of cardiovascular toxicities of immune checkpoint inhibitors;Basic Research in Cardiology;2024-07-17